Hemorheological Alteration in Patients Clinically Diagnosed with Chronic Liver Diseases.
10.3346/jkms.2016.31.12.1943
- Author:
Bohyun JANG
1
;
Ji Won HAN
;
Pil Soo SUNG
;
Jeong Won JANG
;
Si Hyun BAE
;
Jong Young CHOI
;
Young I CHO
;
Seung Kew YOON
Author Information
1. Division of Hepatology, Department of Internal Medicine, The Catholic University of Korea, Seoul St. Mary’s Hospital, Seoul, Korea. yoonsk@catholic.ac.kr
- Publication Type:Original Article
- Keywords:
Hemorheology;
Whole Blood Viscosity;
Chronic Liver Disease
- MeSH:
Blood Viscosity;
Capillaries;
Elasticity Imaging Techniques;
Female;
Hemorheology;
Hepatitis;
Hepatitis B;
Humans;
Liver Cirrhosis;
Liver Diseases*;
Liver*;
Male;
Non-alcoholic Fatty Liver Disease;
Prognosis
- From:Journal of Korean Medical Science
2016;31(12):1943-1948
- CountryRepublic of Korea
- Language:English
-
Abstract:
Since liver function is changed by chronic liver diseases, chronic liver disease can lead to different hemorheological alterations during the course of the progression. This study aims to compare alterations in whole blood viscosity in patients with chronic liver disease, focusing on the gender effect. Chronic liver diseases were classified into three categories by patient’s history, serologic markers, and radiologic findings: nonalcoholic fatty liver disease (NAFLD) (n = 63), chronic viral hepatitis B and C (n = 50), and liver cirrhosis (LC) (n = 35). Whole blood viscosity was measured by automated scanning capillary tube viscometer, while liver stiffness was measured by transient elastography using FibroScan®. Both systolic and diastolic whole blood viscosities were significantly lower in patients with LC than NAFLD and chronic viral hepatitis (P < 0.001) in male patients, but not in female patients. In correlation analysis, there were inverse relationships between both systolic and diastolic whole blood viscosity and liver stiffness (systolic: r = −0.25, diastolic: r = −0.22). Whole blood viscosity was significantly lower in male patients with LC than NAFLD or chronic viral hepatitis. Our data suggest that whole blood viscosity test can become a useful tool for classifying chronic liver disease and determining the prognosis for different types of chronic liver diseases.
